×
About 24,425 results

ALLMedicine™ Dyspnea Center

Research & Reviews  7,627 results

Pulmonary Blastomycosis Imaging
https://emedicine.medscape.com/article/354067-overview

May 20th, 2022 - Practice Essentials Blastomyces dermatitidis is a thermally dimorphic fungus that causes the systemic pyogranulomatous disease termed blastomycosis. This pathogen is endemic to North America, particularly in the states bordering the Mississippi an...

Monkeypox
https://emedicine.medscape.com/article/1134714-overview

May 19th, 2022 - Practice Essentials In 1970, when smallpox was nearly eradicated, a previously unrecognized orthopoxvirus named monkeypox was identified in humans. The first known human case occurred in the Equateur province of Zaire (now known as the Democratic ...

Pneumomediastinum
https://emedicine.medscape.com/article/1003409-overview

May 19th, 2022 - Practice Essentials Pneumomediastinum is an uncommon entity in pediatric practice. It is defined as free air or gas contained within the mediastinum, which almost invariably originates from the alveolar space or the conducting airways. The etiolog...

Effectiveness of a Home-Based Pulmonary Rehabilitation Program in Veterans.
https://doi.org/10.1089/tmj.2022.0050
Telemedicine Journal and E-health : the Official Journal ... Drwal KR, Hurst D et. al.

May 19th, 2022 - Purpose: This study examined the effectiveness and safety of a home-based pulmonary rehabilitation (HBPR) program in Veterans. Methods: Patients were evaluated from five Veteran Affairs facilities that enrolled in the 12-week program. Pre- to post...

Pneumomediastinum
https://emedicine.medscape.com/article/1003409-print

May 19th, 2022 - Practice Essentials Pneumomediastinum is an uncommon entity in pediatric practice. It is defined as free air or gas contained within the mediastinum, which almost invariably originates from the alveolar space or the conducting airways. The etiolog...

see more →

Guidelines  14 results

ACR Appropriateness Criteria® Dyspnea-Suspected Cardiac Origin (Ischemia Already Exclud...
https://doi.org/10.1016/j.jacr.2022.02.014
Journal of the American College of Radiology : JACR; , Bolen MA et. al.

May 14th, 2022 - Dyspnea is the symptom of perceived breathing discomfort and is commonly encountered in a variety of clinical settings. Cardiac etiologies of dyspnea are an important consideration; among these, valvular heart disease (Variant 1), arrhythmia (Vari...

Know Your Guidelines 2022 Series: The ASCO Management of Dyspnea in Advanced Cancer Gui...
https://doi.org/10.14423/SMJ.0000000000001349
Southern Medical Journal; Jackson CD, Schilthuis AJ et. al.

Feb 5th, 2022 - Know Your Guidelines 2022 Series: The ASCO Management of Dyspnea in Advanced Cancer Guideline Review.|2022|Jackson CD,Schilthuis AJ,Guice KC,Payne KS,Dabal TD,|etiology,therapy,complications,therapy,methods,organization & administration,trends,

Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emer...
https://doi.org/10.7326/M20-7844
Annals of Internal Medicine; Qaseem A, Etxeandia-Ikobaltzeta I et. al.

Apr 27th, 2021 - The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the appropriate use of point-of-care ultrasonography (POCUS) in patients with acute dyspnea in emergency department (ED) or inpatient settings...

Emerging challenges in the evaluation of fever in cancer patients at risk of febrile ne...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682766
Supportive Care in Cancer : Official Journal of the Multi... Cooksley T, Font C et. al.

Nov 25th, 2020 - Patients with cancer are at higher risk of more severe COVID-19 infection and have more associated complications. The position paper describes the management of cancer patients, especially those receiving anticancer treatment, during the COVID-19 ...

Acute subglottic laryngitis. Etiology, epidemiology, pathogenesis and clinical picture.
https://doi.org/10.5603/ARM.2019.0056
Advances in Respiratory Medicine; Mazurek H, Bręborowicz A et. al.

Nov 5th, 2019 - In about 3% of children, viral infections of the airways that develop in early childhood lead to narrowing of the laryngeal lumen in the subglottic region resulting in symptoms such as hoarseness, abarking cough, stridor, and dyspnea. These infect...

see more →

Drugs  254 results see all →

Clinicaltrials.gov  594 results

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, ALCHEMIST Chemo-IO Study
https://clinicaltrials.gov/ct2/show/NCT04267848

May 13th, 2022 - PRIMARY OBJECTIVE: I. To compare the disease free survival (DFS) between Arm B versus (vs) Arm C in patients with stage IIA-IIIB (T3-4N2) non-small cell lung cancer. SECONDARY OBJECTIVES: I. To compare the overall survival (OS) between the two tre...

Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
https://clinicaltrials.gov/ct2/show/NCT03505021

May 11th, 2022 - This study will evaluate whether prolonged oral levosimendan can preserve respiratory function more effectively than placebo, resulting in better patient functionality as measured by the ALSFRS-R scale. In this randomized, double-blind, placebo-co...

Hotspot TCR-T: A Phase I/Ib Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)
https://clinicaltrials.gov/ct2/show/NCT04520711

May 10th, 2022 - Patients will be infused with T cells engineered to express TCRs targeting one to five tumor-specific antigens expressed by their autologous tumor. The number of T cells infused will range from 1e9 to 1e11. Monoclonal antibodies targeting PD-1 (pe...

Effects of High-intensity Noninvasive Positive Pressure Ventilation in AECOPD
https://clinicaltrials.gov/ct2/show/NCT04044625

May 10th, 2022 - This study aims to investigate the effects of high-intensity noninvasive positive pressure ventilation (NPPV), as compared with low-intensity NPPV, on hypercapnia, consciousness, inspiratory muscle effort, dyspnea, NPPV tolerance, inflammatory res...

Low Dose Albumin Versus Standard Dose Albumin in High Risk Spontaneous Bacterial Peritonitis.
https://clinicaltrials.gov/ct2/show/NCT04273373

May 10th, 2022 - AIM:- A randomized non-inferiority trial comparing low dose albumin versus standard dose albumin in high risk Spontaneous Bacterial Peritonitis. Methodology In this non-inferior randomized controlled trial one group will receive Low dose albumin: ...

see more →

News  1,272 results

Ob/Gyn Case Challenge: A 33-Year-Old Woman Trying to Conceive Has Dyspnea, Pain
https://www.medscape.com/viewarticle/845962

May 19th, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Online Singing Program Boosts Quality of Life, Not Breathlessness in Long-COVID Patients
https://www.medscape.com/viewarticle/973858

May 13th, 2022 - NEW YORK (Reuters Health) - An online program to help those with breathing issues due to long COVID improved participants' quality of life, but not their breathlessness, a new study finds. The 150 participants were randomly assigned to usual care ...

Second-Line Eftilagimod Alpha Plus Pembrolizumab Shows Promising Activity in Metastatic Lung Cancer
https://www.onclive.com/view/second-line-eftilagimod-alpha-plus-pembrolizumab-shows-promising-activity-in-metastatic-lung-cancer

May 2nd, 2022 - The combination of eftilagimod alpha (IMP321) and pembrolizumab (Keytruda) was found to produce an encouraging early overall survival (OS) rate of 73% at the 6-month landmark when used as second-line treatment in patients with PD-1/PD-L1–refractor...

Ceralasertib Plus Acalabrutinib Shows Early Activity in High-Risk Relapsed/Refractory CLL
https://www.onclive.com/view/ceralasertib-plus-acalabrutinib-shows-early-activity-in-high-risk-relapsed-refractory-cll

Apr 29th, 2022 - The combination of ceralasertib (AZD6738) and acalabrutinib (Calquence) showed preliminary clinical activity with acceptable tolerability in patients with high-risk, relapsed/refractory chronic lymphocytic leukemia (CLL), according to data from a ...

Durvalumab Plus Oleclumab or Monalizumab Induces Increased Response Rates in NSCLC
https://www.onclive.com/view/durvalumab-plus-oleclumab-or-monalizumab-induces-increased-response-rates-in-nsclc

Apr 28th, 2022 - Consolidation therapy with durvalumab (Imfinzi) and either oleclumab or monalizumab showed increased clinical benefits in patients with unresectable stage III non–small cell lung cancer (NSCLC), according to interim data from the phase 2 COAST stu...

see more →

Patient Education  9 results see all →